Hyrtiosenolide B - Compound Card

Hyrtiosenolide B

Select a section from the left sidebar

Hyrtiosenolide B

Structure
Zoomed Structure
  • Family: Animalia - Thorectidae
  • Kingdom: Animalia
  • Class: Terpenoid
    • Subclass: Sesquiterpene Gamma-Methoxybutenolide
Canonical Smiles CO[C@]12OC(=O)C=C1CC[C@@]1(C[C@@H]2C[C@@](C)(O)C1=C)C
InChI InChI=1S/C16H22O4/c1-10-14(2)6-5-11-7-13(17)20-16(11,19-4)12(8-14)9-15(10,3)18/h7,12,18H,1,5-6,8-9H2,2-4H3/t12-,14-,15-,16+/m1/s1
InChIKey SQWYVTVFJMUPOS-MIGQKNRLSA-N
Formula C16H22O4
HBA 4
HBD 1
MW 278.35
Rotatable Bonds 1
TPSA 55.76
LogP 2.33
Number Rings 3
Number Aromatic Rings 0
Heavy Atom Count 20
Formal Charge 0
Fraction CSP3 0.69
Exact Mass 278.15
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Hyrtios species Thorectidae Animalia 279627

Showing of synonyms

  • Youssef DT, Singab AN, et al. (2004). Hyrtiosenolides A and B, two new sesquiterpene gamma-methoxybutenolides and a new sterol from a Red Sea sponge Hyrtios species. Journal of Natural Products,2004,67(10),1736-1739. [View] [PubMed]
Pubchem: 101357705
Nmrshiftdb2: 80012037

No compound-protein relationship available.

Structure

SMILES: C1CC(=C)C(CC2)CC1C(C2=3)OC(=O)C3

Level: 0

Mol. Weight: 278.35 g/mol

Antibacterial

Absorption

Caco-2 (logPapp)
-4.57
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.45
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-2.35

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
0.54
Plasma Protein Binding
40.1
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
7.92
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
0.27
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-0.36
Liver Injury II
Toxic
hERG Blockers
Safe
Daphnia Maga
4.45
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-1.76
Rat (Acute)
2.43
Rat (Chronic Oral)
1.33
Fathead Minnow
3.92
Respiratory Disease
Safe
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
325.28
Hydration Free Energy
-5.34
Log(D) at pH=7.4
1.95
Log(P)
1.82
Log S
-2.76
Log(Vapor Pressure)
-5.01
Melting Point
131.76
pKa Acid
8.36
pKa Basic
5.79
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Lactoylglutathione lyase Q9CPU0 LGUL_MOUSE Mus musculus 2 0.7143
Lactoylglutathione lyase Q9CPU0 LGUL_MOUSE Mus musculus 2 0.7143

Download SDF